Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy

Eric C. Towe, J. Martijn Bos, Steve R. Ommen, Bernard J. Gersh, Michael John Ackerman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Hypertrophic cardiomyopathy is underscored by profound phenotypic and genotypic heterogeneity. Echocardiographically, hypertrophic cardiomyopathy can be categorized into four morphological subtypes: reverse curve, sigmoidal, neutral contour, and apical variant. Previous studies indicate that reverse curve hypertrophic cardiomyopathy is the strongest predictor of a positive genetic test. Little is known about the spectrum and prevalence of mutations and genotype-phenotype correlations in apical hypertrophic cardiomyopathy. Design: Between 1999 and 2007, 1053 patients with the diagnosis of hypertrophic cardiomyopathy (60% male, age at diagnosis 44.4 ± 19 years) underwent sarcomeric genetic testing. Blinded to the genetic test results, each echocardiogram was scored for septal morphology and phenotyping was performed using the patient's medical record. Subset analysis was performed to elucidate the genotype, phenotype, and outcome of apical hypertrophic cardiomyopathy. Results: Overall, 71 patients (7%) had apical hypertrophic cardiomyopathy on echocardiography (63% male, mean age 47.8 ± 15 years, mean left ventricular wall thickness 19.8 ± 6mm). Left ventricular outflow tract obstruction was uncommon (seven patients; 10%). Eighteen patients (25%) had a positive genetic test, with the majority of mutations found in MYBPC3 (six; 35%) and MYH7 (six; 35%). Follow-up was available on 68 patients (96%) with a median age of 57.3 years (range 19.3-82 years). Mean follow-up was 5.5 years (range 0.1-18.2 years). There was no statistical difference between the occurrence rates of adverse events between genotype-positive and genotype-negative groups. Conclusions: In this largest cohort of patients with genetic testing for hypertrophic cardiomyopathy, <10% exhibited apical disease. This least common subtype was associated with a negative genetic test result 75% of the time. In contrast to prior publications suggesting a predilection for ACTC1/TPM1 mutations in patients with apical hypertrophic cardiomyopathy, the two most common genotypes (MYBPC3-HCM and MYH7-HCM) remained most common among patients who had a positive genetic test.

Original languageEnglish (US)
Pages (from-to)E139-E145
JournalCongenital Heart Disease
Volume10
Issue number3
DOIs
StatePublished - May 1 2015

Fingerprint

Hypertrophic Cardiomyopathy
Genetic Association Studies
Genotype
Genetic Testing
Mutation
Ventricular Outflow Obstruction
Medical Records
Echocardiography
Publications
Phenotype

Keywords

  • Adult
  • Apical Hypertrophic Cardiomyopathy
  • Congenital Heart Disease
  • Genetic Testing
  • Hypertrophic Cardiomyopathy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health
  • Surgery
  • Radiology Nuclear Medicine and imaging

Cite this

Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy. / Towe, Eric C.; Bos, J. Martijn; Ommen, Steve R.; Gersh, Bernard J.; Ackerman, Michael John.

In: Congenital Heart Disease, Vol. 10, No. 3, 01.05.2015, p. E139-E145.

Research output: Contribution to journalArticle

Towe, Eric C. ; Bos, J. Martijn ; Ommen, Steve R. ; Gersh, Bernard J. ; Ackerman, Michael John. / Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy. In: Congenital Heart Disease. 2015 ; Vol. 10, No. 3. pp. E139-E145.
@article{0174d3c3301d4c29960aff6b77437bcb,
title = "Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy",
abstract = "Objective: Hypertrophic cardiomyopathy is underscored by profound phenotypic and genotypic heterogeneity. Echocardiographically, hypertrophic cardiomyopathy can be categorized into four morphological subtypes: reverse curve, sigmoidal, neutral contour, and apical variant. Previous studies indicate that reverse curve hypertrophic cardiomyopathy is the strongest predictor of a positive genetic test. Little is known about the spectrum and prevalence of mutations and genotype-phenotype correlations in apical hypertrophic cardiomyopathy. Design: Between 1999 and 2007, 1053 patients with the diagnosis of hypertrophic cardiomyopathy (60{\%} male, age at diagnosis 44.4 ± 19 years) underwent sarcomeric genetic testing. Blinded to the genetic test results, each echocardiogram was scored for septal morphology and phenotyping was performed using the patient's medical record. Subset analysis was performed to elucidate the genotype, phenotype, and outcome of apical hypertrophic cardiomyopathy. Results: Overall, 71 patients (7{\%}) had apical hypertrophic cardiomyopathy on echocardiography (63{\%} male, mean age 47.8 ± 15 years, mean left ventricular wall thickness 19.8 ± 6mm). Left ventricular outflow tract obstruction was uncommon (seven patients; 10{\%}). Eighteen patients (25{\%}) had a positive genetic test, with the majority of mutations found in MYBPC3 (six; 35{\%}) and MYH7 (six; 35{\%}). Follow-up was available on 68 patients (96{\%}) with a median age of 57.3 years (range 19.3-82 years). Mean follow-up was 5.5 years (range 0.1-18.2 years). There was no statistical difference between the occurrence rates of adverse events between genotype-positive and genotype-negative groups. Conclusions: In this largest cohort of patients with genetic testing for hypertrophic cardiomyopathy, <10{\%} exhibited apical disease. This least common subtype was associated with a negative genetic test result 75{\%} of the time. In contrast to prior publications suggesting a predilection for ACTC1/TPM1 mutations in patients with apical hypertrophic cardiomyopathy, the two most common genotypes (MYBPC3-HCM and MYH7-HCM) remained most common among patients who had a positive genetic test.",
keywords = "Adult, Apical Hypertrophic Cardiomyopathy, Congenital Heart Disease, Genetic Testing, Hypertrophic Cardiomyopathy",
author = "Towe, {Eric C.} and Bos, {J. Martijn} and Ommen, {Steve R.} and Gersh, {Bernard J.} and Ackerman, {Michael John}",
year = "2015",
month = "5",
day = "1",
doi = "10.1111/chd.12242",
language = "English (US)",
volume = "10",
pages = "E139--E145",
journal = "Congenital Heart Disease",
issn = "1747-079X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy

AU - Towe, Eric C.

AU - Bos, J. Martijn

AU - Ommen, Steve R.

AU - Gersh, Bernard J.

AU - Ackerman, Michael John

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objective: Hypertrophic cardiomyopathy is underscored by profound phenotypic and genotypic heterogeneity. Echocardiographically, hypertrophic cardiomyopathy can be categorized into four morphological subtypes: reverse curve, sigmoidal, neutral contour, and apical variant. Previous studies indicate that reverse curve hypertrophic cardiomyopathy is the strongest predictor of a positive genetic test. Little is known about the spectrum and prevalence of mutations and genotype-phenotype correlations in apical hypertrophic cardiomyopathy. Design: Between 1999 and 2007, 1053 patients with the diagnosis of hypertrophic cardiomyopathy (60% male, age at diagnosis 44.4 ± 19 years) underwent sarcomeric genetic testing. Blinded to the genetic test results, each echocardiogram was scored for septal morphology and phenotyping was performed using the patient's medical record. Subset analysis was performed to elucidate the genotype, phenotype, and outcome of apical hypertrophic cardiomyopathy. Results: Overall, 71 patients (7%) had apical hypertrophic cardiomyopathy on echocardiography (63% male, mean age 47.8 ± 15 years, mean left ventricular wall thickness 19.8 ± 6mm). Left ventricular outflow tract obstruction was uncommon (seven patients; 10%). Eighteen patients (25%) had a positive genetic test, with the majority of mutations found in MYBPC3 (six; 35%) and MYH7 (six; 35%). Follow-up was available on 68 patients (96%) with a median age of 57.3 years (range 19.3-82 years). Mean follow-up was 5.5 years (range 0.1-18.2 years). There was no statistical difference between the occurrence rates of adverse events between genotype-positive and genotype-negative groups. Conclusions: In this largest cohort of patients with genetic testing for hypertrophic cardiomyopathy, <10% exhibited apical disease. This least common subtype was associated with a negative genetic test result 75% of the time. In contrast to prior publications suggesting a predilection for ACTC1/TPM1 mutations in patients with apical hypertrophic cardiomyopathy, the two most common genotypes (MYBPC3-HCM and MYH7-HCM) remained most common among patients who had a positive genetic test.

AB - Objective: Hypertrophic cardiomyopathy is underscored by profound phenotypic and genotypic heterogeneity. Echocardiographically, hypertrophic cardiomyopathy can be categorized into four morphological subtypes: reverse curve, sigmoidal, neutral contour, and apical variant. Previous studies indicate that reverse curve hypertrophic cardiomyopathy is the strongest predictor of a positive genetic test. Little is known about the spectrum and prevalence of mutations and genotype-phenotype correlations in apical hypertrophic cardiomyopathy. Design: Between 1999 and 2007, 1053 patients with the diagnosis of hypertrophic cardiomyopathy (60% male, age at diagnosis 44.4 ± 19 years) underwent sarcomeric genetic testing. Blinded to the genetic test results, each echocardiogram was scored for septal morphology and phenotyping was performed using the patient's medical record. Subset analysis was performed to elucidate the genotype, phenotype, and outcome of apical hypertrophic cardiomyopathy. Results: Overall, 71 patients (7%) had apical hypertrophic cardiomyopathy on echocardiography (63% male, mean age 47.8 ± 15 years, mean left ventricular wall thickness 19.8 ± 6mm). Left ventricular outflow tract obstruction was uncommon (seven patients; 10%). Eighteen patients (25%) had a positive genetic test, with the majority of mutations found in MYBPC3 (six; 35%) and MYH7 (six; 35%). Follow-up was available on 68 patients (96%) with a median age of 57.3 years (range 19.3-82 years). Mean follow-up was 5.5 years (range 0.1-18.2 years). There was no statistical difference between the occurrence rates of adverse events between genotype-positive and genotype-negative groups. Conclusions: In this largest cohort of patients with genetic testing for hypertrophic cardiomyopathy, <10% exhibited apical disease. This least common subtype was associated with a negative genetic test result 75% of the time. In contrast to prior publications suggesting a predilection for ACTC1/TPM1 mutations in patients with apical hypertrophic cardiomyopathy, the two most common genotypes (MYBPC3-HCM and MYH7-HCM) remained most common among patients who had a positive genetic test.

KW - Adult

KW - Apical Hypertrophic Cardiomyopathy

KW - Congenital Heart Disease

KW - Genetic Testing

KW - Hypertrophic Cardiomyopathy

UR - http://www.scopus.com/inward/record.url?scp=84933675158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933675158&partnerID=8YFLogxK

U2 - 10.1111/chd.12242

DO - 10.1111/chd.12242

M3 - Article

VL - 10

SP - E139-E145

JO - Congenital Heart Disease

JF - Congenital Heart Disease

SN - 1747-079X

IS - 3

ER -